Major Pharma News


Share
Posted in News | Leave a comment

ACS Careers

  • Entrepreneurship. R&D Funding Available from the Federal Small Business Administration January 16, 2012
    The Small Business Administration (SBA), a unit of the U.S. Department of Commerce, offers two programs to assist entrepreneurs with research & development (R&D) costs. Small Business Administration Innovation Research Program (SBIR) SBIR funding is 2.5% of the total extramural research budgets of all federal agencies with extramural research budgets of more than of $100 [...]
  • Entrepreneurship. Business Incubators and their Services January 9, 2012
    Business incubators are facilities that provide entrepreneurs with an inexpensive start-up environment and a range of administrative, consulting, and networking services.  According to a 2010 study by the National Business Incubation Association (NBIA), the survival rate of startups using business incubators is 87% compared t0 44% for startups that didn’t use incubators.   At that time [...]

Share
Posted in Job | Leave a comment

Nanomedicine

[Perspectives] Dodging Drug-Resistant Cancer with Diamonds

When treating metastatic tumors, chemoresistance can cause problems. A report in this issue of Science Translational Medicine demonstrates the potential of nanodiamond carriers (2 to 8 nanometers) for treating cancers with drug-efflux–based chemoresistance. Nanodiamond-mediated delivery of the chemotherapeutic doxorubicin (Dox) allowed for prolonged activity and increased apoptosis with decreased toxicity when compared with free Dox in liver cancer cells in culture as well as in vivo in mouse liver tumors. This finding may represent a broadly applicable strategy for overcoming adenosine 5′-triphosphate (ATP)–binding cassette (ABC) drug transporter–mediated resistance during cancer chemotherapy.

Merkel, T. J., DeSimone, J. M

Share
Posted in Research | Leave a comment

In The Pipeline

Buy.com

By Derek Lowe

Note: Other Chemistry blogs under “Panopharma”.

  • Roche Goes Hostile for Illumina January 27, 2012
    Roche is not only a big drug company, it's a big diagnostics company. And that's what's driving their unsolicited bid for Illumina, a gene-sequencing company from San Diego. Illumina has been one of the big players in the "How quickly and cheaply can we sequence a person's entire genome" game, and apparently Roche believes that there's something in it for them. But as that Reuters link above shows, a lot of other people don't agree, and would rather partner than acquire (Chris Viehbacher, CEO of Sanofi, seems to have been waiting for the opportunity to unburden himself of thoughts to that effect). He may well be right. Sequencing has been a can-you-top-this field for some time, and I don't think that the process is finished yet. What if you buy a technology that's superseded before it has the time to pay off? What if the market for sequencing doesn't get as large, as quickly, as you're hoping? Those were Illumina's worries, and now they're going to be Roche's; you can't buy the promise without buying those, too. Matthew Herper at Forbes is having very similar thoughts, and points out that Roche has done this sort of thing before. For now, we'll see what Illumina might be able to come up with to avoid being Roched.
  • Arsenic Bacteria Ride Again. (Or Don't). January 27, 2012
    You may not have heard much about the arsenic-bacteria controversy recently, but you're about to hear quite a bit more. Rosie Redfield of UBC, one of the fastest and most vocal critics of the original paper, has been trying to reproduce it in her own group. There's a manuscript in preparation, but since she's been blogging on some of the progress, the import is clear: it hasn't been going well for the "bacteria can take up arsenic in their biomolecules" hypothesis. Scrolling back at that link will give you the story. Here's a summary at Nature News (with a clarification from Redfield on one point). I look forward to seeing how this plays out - but remember, the startling results always have to prove themselves by happening again. Einmal ist keinmal. Update: there's another story here, too. Redfield has been posting results as they come along, in a very prominent example of "open science". The first question is: will this affect journal publication? That is, will some editors look askance? The second point is to be found in that Nature News article, where Felisa Wolfe-Simon refers to those "website experiments", and how she basically can't discuss them until she sees them in a journal. Note that it's not "the UBC experiments" or "Redfield's experiments" - they're "website experiments", and thus (apparently) have more to prove.

Share
Posted in General | Leave a comment

Worldwide Chemistry & Biochemistry Departments

  • A: Afghanistan | Albania | Algeria | Angola | Argentina | Armenia | Australia | Austria | Azerbaijan
  • B: Bahrain | Bangladesh | Barbados | Belarus | Belgium | Benin | Bhutan | Bolivia | Bosnia and Herzegovina | Botswana | Brazil | Brunei Darussalam | Bulgaria | Burkina Faso
  • C: Cambodia | Cameroon | Canada | Cape Verde | Central African Republic | Chile | China | Colombia | Congo (Democratic Republic) | Costa Rica | Côte d’Ivoire | Croatia | Cuba | Cyprus | Czech Republic
  • D: Denmark | Djibouti| | Dominican Republic
  • E: Ecuador | Egypt | El Salvador | Eritrea | Estonia | Ethiopia
  • F: Fiji | Finland | France | French Polynesia
  • G: Gabon | Georgia | Germany | Ghana | Greece | Grenada | Guam | Guatemala | Guyana
  • H: Honduras | Hong Kong | Hungary
  • I: Iceland | India | Indonesia | Iran | Iraq | Ireland | Israel |  Italy
  • J: Jamaica | Japan | Jordan
  • K: Kazakhstan | Kenya | Kuwait |Kyrgyzstan
  • L: Laos | Latvia | Lebanon | Lesotho | Liberia | Libya | Lithuania
  • M: Macedonia | Madagascar | Malawi | Malaysia | Mali | Malta | Mauritania | Mauritius | Mexico | Moldova | Mongolia | Montenegro | Morocco | Mozambique | Myanmar
  • N: Namibia | Nepal | Netherlands | New Zealand | Nicaragua | Nigeria | Norway
  • O: Oman
  • P: Pakistan | Palestinian Authority | Panama | Papua New Guinea | Paraguay | Peru | Philippines | Poland | Portugal | Puerto Rico
  • Q: Qatar
  • R: Romania | Russia | Rwanda
  • S: Saudi Arabia | Senegal | Serbia | Singapore | Slovakia | Slovenia | Somalia | South Africa | South Korea | Spain | Sri Lanka | Sudan | Swaziland | Sweden | Switzerland
  • T: Taiwan | Tanzania | Thailand | Togo | Trinidad and Tobago | TunisiaTurkey | Turkmenistan
  • U: Uganda | Ukraine | United Arab Emirates| United Kingdom | Uruguay | Uzbekistan
  • V: Venezuela | Vietnam | Virgin Islands (U.S.)
  • W: none
  • X: none
  • Y: Yemen
  • Z: Zambia | Zimbabwe
  • Share
    Posted in General | Leave a comment

    US Chemistry & Biochemistry Departments

    Alphabetical by University Name:

    A  *  B  * C  * D  *  E  * F  *  GH 

    I  * J  *   K  *  L  *  M  *  N  *  O  *  P   

    QR  *  S  *  T  *  U  *  V  *  W  *  X  * Y

    By State:

    Alabama Kentucky North Dakota
    Alaska Louisiana Ohio
    Arizona Maine Oklahoma
    Arkansas Maryland Oregon
    California Massachusetts Pennsylvania
    Colorado Michigan Rhode Island
    Connecticut Minnesota South Carolina
    Delaware Mississippi South Dakota
    District of Columbia Missouri Tennessee
    Florida Montana Texas
    Georgia Nebraska Utah
    Hawaii Nevada Vermont
    Idaho New Hampshire Virginia
    Illinois New Jersey Washington
    Indiana New Mexico West Virginia
    Iowa New York Wisconsin
    Kansas North Carolina Wyoming
    Share
    Posted in General | Leave a comment

    Periodic Table

    Dynamic Periodic Table – An interactive periodic table

    Visual Elements Periodic Table - A striking representation of the chemical elements drawing on the symbolism that surrounds them from the commonplace to the mythological

    Share
    Posted in General | Leave a comment

    ScienceNOW Daily Headlines


    Share
    Posted in News | Leave a comment

    This Week in Science

    • Locust Heaven
      Locust outbreaks have severe consequences for agriculture, but the conditions that promote an outbreak are unknown. Cease et al. (p. 467) investigated aspects of the locust diet and found that … [Read more]
    • Natural Selection Caught in the Act
      Understanding how new functions evolve has been of long-standing interest. However, the number of mutations needed to evolve a key innovation is rarely known, or whether other sets of mutations … [Read more]
    • Potassium Permeation
      Two–pore domain potassium (K2P) channels conduct K+ ions across the plasma membrane of eukaryotic cells. They help to maintain the cellular resting potential and their modulation can tune cellular excitability … [Read more]
    • Porous Membranes
      Thin semi-permeable membranes are commonly used as chemical barriers or for filtration purposes. While the size of the pores will influence which molecules are able to pass, other factors—including the … [Read more]
    • Boxing in Peroxide
      Hydrogen peroxide (H2O2) is a powerful oxidant, and its reactivity is exploited in numerous biological, as well as synthetic, contexts. Lopez et al. (p. 450) have now managed to capture … [Read more]
    • Centrosome Center Stage?
      The centrosome is a major organizer of the cytoskeleton in animal cells. The precise duplication of this organelle at each cell cycle ensures proper organization of the mitotic apparatus and … [Read more]
    • Magnetic Moon
      It has long been suspected that the Moon once had a core-dynamo magnetic field. Shea et al. (p. 453) describe a lunar basalt brought back by Apollo 11 that records … [Read more]
    • Forest Diversification
      The relative role of neutral and deterministic processes in generating species richness in ecological communities (particularly tropical trees) has dominated recent discussions about patterns of diversity and abundance of species. … [Read more]
    • A Good Judge of Distance
      Jumping spiders actively pursue their prey, often jumping relatively long distances in order to catch them. Such feats require accurate depth perception. Nagata et al. (p. 469; see the Perspective … [Read more]
    • A Passive Optical Diode
      Electrical diodes are at the core of microelectronics. The optical equivalent, however, has been difficult to realize owing to the time-reversal symmetry of Maxwell's equations that describe electromagnetic propagation. Usually, … [Read more]

    Share
    Posted in Research | Leave a comment

    Science Translational Medicine weekly highlights

    • [Commentary] Triggers for Research Ethics Consultation
      Research ethics consultation services are designed to help scientists address ethical and societal issues that may not be considered in the context of existing regulatory frameworks, such as institutional review boards. Here, we identify some types of biomedical research for which the research process can benefit from consultation with ethicists.
      Havard, M., Cho, M. K., Magnus, D.
    • [Commentary] A Virtual National Laboratory for Reengineering Clinical Translational Science
      Clinical research is burdened by inefficiencies and complexities, with a poor record of trial completion, none of which is desirable. The Clinical and Translational Science Award (CTSA) Consortium, including more than 60 clinical research institutions, supports a unified national effort to become, in effect, a virtual national laboratory designed to identify, implement, evaluate, and extend process improvements across all parts of clinical research, from conception to completion. If adequately supported by academic health centers, industry, and funding agencies, the Consortium could become a test bed for improvements that can dramatically reduce wasteful complexity, thus increasing the likelihood of clinical trial completion.
      Dilts, D. M., Rosenblum, D., Trochim, W. M.
    • [Research Articles] Molecular Diagnosis of Infantile Mitochondrial Disease with Targeted Next-Generation Sequencing
      Advances in next-generation sequencing (NGS) promise to facilitate diagnosis of inherited disorders. Although in research settings NGS has pinpointed causal alleles using segregation in large families, the key challenge for clinical diagnosis is application to single individuals. To explore its diagnostic use, we performed targeted NGS in 42 unrelated infants with clinical and biochemical evidence of mitochondrial oxidative phosphorylation disease. These devastating mitochondrial disorders are characterized by phenotypic and genetic heterogeneity, with more than 100 causal genes identified to date. We performed "MitoExome" sequencing of the mitochondrial DNA (mtDNA) and exons of ~1000 nuclear genes encoding mitochondrial proteins and prioritized rare mutations predicted to disrupt function. Because patients and healthy control individuals harbored a comparable number of such heterozygous alleles, we could not prioritize dominant-acting genes. However, patients showed a fivefold enrichment of genes with two such mutations that could underlie recessive disease. In total, 23 of 42 (55%) patients harbored such recessive genes or pathogenic mtDNA variants. Firm diagnoses were enabled in 10 patients (24%) who had mutations in genes previously linked to disease. Thirteen patients (31%) had mutations in nuclear genes not previously linked to disease. The pathogenicity of two such genes, NDUFB3 and AGK, was supported by complementation studies and evidence from multiple patients, respectively. The results underscore the potential and challenges of deploying NGS in clinical settings.
      Calvo, S. E., Compton, A. G., Hershman, S. G., Lim, S. C., Lieber, D. S., Tucker, E. J., Laskowski, A., Garone, C., Liu, S., Jaffe, D. B., Christodoulou, J., Fletcher, J. M., Bruno, D. L., Goldblatt, J., DiMauro, S., Thorburn, D. R., Mootha, V. K.
    • [Research Articles] Surgical Stress Resistance Induced by Single Amino Acid Deprivation Requires Gcn2 in Mice
      Dietary restriction, or reduced food intake without malnutrition, increases life span, health span, and acute stress resistance in model organisms from yeast to nonhuman primates. Although dietary restriction is beneficial for human health, this treatment is not widely used in the clinic. Here, we show that short-term, ad libitum feeding of diets lacking essential nutrients increased resistance to surgical stress in a mouse model of ischemia reperfusion injury. Dietary preconditioning by 6 to 14 days of total protein deprivation, or removal of the single essential amino acid tryptophan, protected against renal and hepatic ischemic injury, resulting in reduced inflammation and preserved organ function. Pharmacological treatment with halofuginone, which activated the amino acid starvation response within 3 days by mimicking proline deprivation, was also beneficial. Both dietary and pharmacological interventions required the amino acid sensor and eIF2α (eukaryotic translation initiation factor 2α) kinase Gcn2 (general control nonderepressible 2), implicating the amino acid starvation response and translational control in stress protection. Thus, short-term dietary or pharmacological interventions that modulate amino acid sensing can confer stress resistance in models of surgical ischemia reperfusion injury.
      Peng, W., Robertson, L., Gallinetti, J., Mejia, P., Vose, S., Charlip, A., Chu, T., Mitchell, J. R.
    • [Editors' Choice] Bidirectional Dance of Glutamine
      Emadi, A.
    • [Research Articles] Teplizumab Induces Human Gut-Tropic Regulatory Cells in Humanized Mice and Patients
      The development and optimization of immune therapies in patients has been hampered by the lack of preclinical models in which their effects on human immune cells can be studied. As a result, observations that have been made in preclinical studies have suggested mechanisms of drug action in murine models that have not been confirmed in clinical studies. Here, we used a humanized mouse reconstituted with human hematopoietic stem cells to study the mechanism of action of teplizumab, an Fc receptor nonbinding humanized monoclonal antibody to CD3 being tested in clinical trials for the treatment of patients with type 1 diabetes mellitus. In this model, human gut-tropic CCR6+ T cells exited the circulation and secondary lymph organs and migrated to the small intestine. These cells then produced interleukin-10 (IL-10), a regulatory cytokine, in quantities that could be detected in the peripheral circulation. Blocking T cell migration to the small intestine with natalizumab, which prevents cellular adhesion by inhibiting α4 integrin binding, abolished the treatment effects of teplizumab. Moreover, IL-10 expression by CD4+CD25highCCR6+FoxP3 cells returning to the peripheral circulation was increased in patients with type 1 diabetes treated with teplizumab. These findings demonstrate that humanized mice may be used to identify novel immunologic mechanisms that occur in patients treated with immunomodulators.
      Waldron-Lynch, F., Henegariu, O., Deng, S., Preston-Hurlburt, P., Tooley, J., Flavell, R., Herold, K. C.
    • [Editors' Choice] When Fat Gets on Your Nerves
      Mashour, G. A.
    • [Editors' Choice] Just Be "pH"-tient
      Rytting, E.
    • [Editors' Choice] Smoking Out a New Therapy for Lung Disease
      Shum, A. K.

    Share
    Posted in Research | Leave a comment